UBS AM
TMDX icon

UBS AM’s Transmedics TMDX Stock Holding History

UBS AM’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.5M Sell
398,250
-541,273
-58% -$45.8M ﹤0.01% 831
2026
Q1 		$93.4M Sell
939,523
-57,355
-6% -$7.48M 0.02% 523
2025
Q4 		$121M Sell
996,878
-72,614
-7% -$9.11M 0.03% 452
2025
Q3 		$120M Buy
1,069,492
+113,817
+12% +$13.3M 0.03% 446
2025
Q2 		$128M Sell
955,675
-2,157,407
-69% -$237M 0.03% 488
2025
Q1 		$209M Buy
3,113,082
+2,209,996
+245% +$152M 0.05% 351
2024
Q4 		$56.3M Buy
903,086
+558,474
+162% +$52M 0.01% 638
2024
Q3 		$54.1M Sell
344,612
-13,807
-4% -$2.13M 0.01% 661
2024
Q2 		$54M Buy
358,419
+315,589
+737% +$37.9M 0.02% 602
2024
Q1 		$3.17M Hold
42,830
– – ﹤0.01% 1464
2023
Q4 		$3.38M Sell
42,830
-4,304
-9% -$260K ﹤0.01% 1440
2023
Q3 		$2.58M Buy
47,134
+5,965
+14% +$429K ﹤0.01% 1493
2023
Q2 		$3.12M Hold
41,169
– – ﹤0.01% 1434
2023
Q1 		$3.12M Buy
41,169
+1,947
+5% +$135K ﹤0.01% 1434
2022
Q4 		$2.42M Buy
39,222
+8,385
+27% +$446K ﹤0.01% 1449
2022
Q3 		$1.29M Sell
30,837
-1,904
-6% -$82.8K ﹤0.01% 1819
2022
Q2 		$1.03M Hold
32,741
– – ﹤0.01% 1943
2022
Q1 		$882K Buy
32,741
+2,911
+10% +$52.2K ﹤0.01% 2204
2021
Q4 		$572K Hold
29,830
– – ﹤0.01% 2504
2021
Q3 		$987K Buy
29,830
+6,049
+25% +$185K ﹤0.01% 2171
2021
Q2 		$789K Buy
+23,781
New +$659K ﹤0.01% 2337

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

UBS AM's TMDX Position: Q2 2026 in Review

UBS AM reduced its Transmedics (TMDX) stake by 58% in Q2 2026, selling an estimated $45.8M and leaving 398,250 shares worth $26.5M. The position accounts for ﹤0.01% of the portfolio, ranked #831.

UBS AM first reported a position in TMDX in Q2 2021 and has held it in 21 quarters since. The position peaked at $209M in Q1 2025. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • UBS AM held 398,250 shares of Transmedics worth $26.5M as of Q2 2026.
  • UBS AM sold 541,273 Transmedics shares in Q2 2026, an estimated $45.8M.
  • Transmedics made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #831 holding.
  • UBS AM first reported a position in Transmedics in Q2 2021 and has held it in 21 quarters since.
  • UBS AM's Transmedics position peaked at $209M in Q1 2025.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.